Keizman D - Search Results

1

Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma.

Keizman D, Ish-Shalom M, Pili R, Hammers H, Eisenberger MA, Sinibaldi V, Boursi B, Maimon N, Gottfried M, Hayat H, Peer A, Kovel S, Sella A, Berger R, Carducci MA. Keizman D, et al. Eur J Cancer. 2012 May;48(7):1031-7. doi: 10.1016/j.ejca.2012.02.050. Epub 2012 Mar 10. Eur J Cancer. 2012. PMID: 22409947

2

Recurrent symptomatic common bile duct stones after endoscopic stone extraction in elderly patients.

Keizman D, Ish Shalom M, Konikoff FM. Keizman D, et al. Gastrointest Endosc. 2006 Jul;64(1):60-5. doi: 10.1016/j.gie.2006.01.022. Gastrointest Endosc. 2006. PMID: 16813804

3

The clinical significance of bile duct sludge: is it different from bile duct stones?

Keizman D, Ish-Shalom M, Konikoff FM. Keizman D, et al. Surg Endosc. 2007 May;21(5):769-73. doi: 10.1007/s00464-006-9153-0. Epub 2007 Mar 7. Surg Endosc. 2007. PMID: 17342562

4

Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis.

Keizman D, Rogowski O, Berliner S, Ish-Shalom M, Maimon N, Nefussy B, Artamonov I, Drory VE. Keizman D, et al. Acta Neurol Scand. 2009 Jun;119(6):383-9. doi: 10.1111/j.1600-0404.2008.01112.x. Epub 2008 Oct 23. Acta Neurol Scand. 2009. PMID: 18976328

5

Expression and significance of EGFR in malignant peripheral nerve sheath tumor.

Keizman D, Issakov J, Meller I, Maimon N, Ish-Shalom M, Sher O, Merimsky O. Keizman D, et al. J Neurooncol. 2009 Sep;94(3):383-8. doi: 10.1007/s11060-009-9862-z. Epub 2009 Mar 28. J Neurooncol. 2009. PMID: 19330289

6

Low uric acid levels in serum of patients with ALS: further evidence for oxidative stress?

Keizman D, Ish-Shalom M, Berliner S, Maimon N, Vered Y, Artamonov I, Tsehori J, Nefussy B, Drory VE. Keizman D, et al. J Neurol Sci. 2009 Oct 15;285(1-2):95-9. doi: 10.1016/j.jns.2009.06.002. Epub 2009 Jun 24. J Neurol Sci. 2009. PMID: 19552925

7

LHRH antagonists vs LHRH agonists: which is more beneficial in prostate cancer therapy?

Keizman D, Eisenberger MA. Keizman D, et al. Oncology (Williston Park). 2009 Jun;23(7):631-2. Oncology (Williston Park). 2009. PMID: 19626831 No abstract available.

8

Intermittent androgen deprivation--questions remain.

Keizman D, Carducci MA. Keizman D, et al. Nat Rev Urol. 2009 Aug;6(8):412-4. doi: 10.1038/nrurol.2009.145. Nat Rev Urol. 2009. PMID: 19657375 No abstract available.

9

An animal model for chemotherapy-associated steatohepatitis and its prevention by the oral administration of fatty acid bile acid conjugate.

Keizman D, Maimon N, Ish-Shalom M, Buchbut D, Inbar M, Klein B, Bernheim J, Goldiner I, Leikin-Frenkel A, Konikoff F. Keizman D, et al. Cancer. 2010 Jan 1;116(1):251-5. doi: 10.1002/cncr.24710. Cancer. 2010. PMID: 19890960 Free article.

10

Is there a role for chemotherapy in nonmetastatic prostate cancer?

Keizman D, Eisenberger M. Keizman D, et al. Curr Opin Support Palliat Care. 2010 Sep;4(3):141-6. doi: 10.1097/SPC.0b013e32833c6cfe. Curr Opin Support Palliat Care. 2010. PMID: 20613534 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters